Oligonucleotide Library Market Size, Share, Growth and Industry Analysis, By Type (12K different oligonucleotides per pool, 90,000 different oligonucleotides per pool), By Application (Target capture, CRISPR/Cas9 design, Gene synthesis, Library preparation, other), Regional Insights and Forecast From 2025 To 2035

• 

  Download Free Sample to learn more about this report

OLIGONUCLEOTIDE LIBRARY MARKET OVERVIEW

The global oligonucleotide library market is anticipated to witness consistent growth, starting from USD 0.52 billion in 2025, reaching USD 0.56 billion in 2026, and climbing to USD 0.98 billion by 2035, at a steady CAGR of 6.4%.

The market has grown significantly in recent years due to genomics and personalized medicine developments. The use of oligonucleotide libraries, which are collections of short DNA or RNA sequences, ranges from drug discovery to target recognition to gene expression profiling. These collections offer scientists access to a wealth of genomic data that will hasten the creation of novel treatments and diagnostic tools.

A wide variety of sequences are included in randomized oligonucleotide libraries, enabling researchers to examine a variety of genetic variants. These libraries are frequently used in drug development and target identification, where the objective is to find compounds that can block particular biological processes or bind specifically to specific targets. Nucleotide sequence locations are regularly changed to build combinatorial oligonucleotide libraries. With the help of this method, huge libraries containing millions or even billions of distinct sequences can be produced. In molecular biology, combinatorial libraries are frequently utilized for tasks including DNA sequencing, protein engineering, and gene synthesis. Degenerate oligonucleotide libraries are made to include nucleotide mixes at particular places along the sequence. Utilizing all feasible nucleotide combinations at a specific place, this method enables examining a broad spectrum of genetic variants. In protein engineering, where the objective is to find amino acid substitutions that enhance protein stability or function, degenerate libraries are frequently utilized.

KEY FINDINGS

COVID-19 IMPACT

Urgent Need For Diagnostic Tests, Vaccines, And Therapeutics Accelerated The Market Growth 

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the Oligonucleotide library market growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 pandemic has significantly impacted this market. On the one hand, the pressing need for medicines, vaccines, and diagnostics has raised the need for it. The need for these libraries is fueled by the necessity of oligonucleotides in PCR-based diagnostic tests and RNA-based vaccinations. On the other hand, the manufacture and delivery of oligonucleotide libraries have been impacted by the pandemic's disruption of worldwide supply chains and logistical difficulties. The implementation of lockdown measures by several nations has led to the shutdown of manufacturing facilities and transit restrictions, delaying the supply of goods. Additionally, the pandemic's economic effects have reduced research funding, which could immediately affect the market.

LATEST TRENDS

Development Of High-Throughput Sequencing Technologies Boosts Market Expansion

High-throughput sequencing methods are one of the newest industry trends for oligonucleotide libraries. Using these tools, scientists can quickly analyze huge oligonucleotide libraries, enabling quicker and more effective screening of prospective drug candidates or genetic variations. Genomics has revolutionized due to high-throughput sequencing, which has also greatly sped up the search for new therapeutic targets. Incorporating artificial intelligence (AI) and machine learning (ML) techniques in library construction and analysis is another new trend in this market. Large datasets can be analyzed by AI and ML algorithms to find patterns or links that may not be obvious to human researchers. This can help to improve screening effectiveness, optimize library designs, and raise the overall success rate of drug discovery initiatives.

• According to the U.S. National Institutes of Health (NIH), over 4,600 oligonucleotide-based clinical trials were registered globally by 2023 — a 32% increase from 2020. The NIH highlighted that advancements in gene synthesis and CRISPR-Cas9 gene editing have accelerated demand for customized oligonucleotide libraries in diagnostics and therapeutic research.

• According to the European Medicines Agency (EMA), approximately 27% of new biotechnological drug applications submitted in 2023 included oligonucleotide sequences as part of their formulation or targeting mechanism. This reflects a 21% rise in utilization of synthetic DNA and RNA libraries for mRNA vaccine development and antisense oligonucleotide studies across Europe.

Download Free Sample to learn more about this report

OLIGONUCLEOTIDE LIBRARY MARKET SEGMENTATION

By Type

The Oligonucleotide library market can be segmented into 12K different oligonucleotides per pool and 90,000 different oligonucleotides per pool.

Among these, 12K different oligonucleotides per pool is projected to experience rapid growth through 2035.

By Application

The market can be divided based on application into target capture, CRISPR/CAS9 design, gene synthesis, library preparation, and other.

Target capture is expected to hold the most Oligonucleotide library market in the upcoming years.

DRIVING FACTORS

Increasing Demand for Personalized Medicine to Propel Market Expansion

The rising emphasis on personalized medicine is driving the demand for oligonucleotide libraries. Personalized medicine aims to modify medical procedures by a patient's genetic profile, enabling more precise and successful therapy. To find genetic variations that can be utilized to create individualized treatments and diagnostics, oligonucleotide libraries are essential.

Rising Investments in Genomics Research to Fuel Market Growth

This market has grown due to the rising investments in genomics research. To better understand the genetic causes of diseases and create cutting-edge treatments, governments, academic institutions, and pharmaceutical corporations are making significant investments in genomics research. These are crucial tools in genomics research to study the immense terrain of genetic data and derive new insights.

• According to the U.S. Food and Drug Administration (FDA), there were over 16 approved oligonucleotide-based therapies as of 2023, compared to just 8 in 2020. The increase in regulatory acceptance has encouraged greater investments in oligonucleotide library synthesis platforms for both preclinical and commercial-scale manufacturing.

• According to Japan’s Ministry of Health, Labour and Welfare (MHLW), research spending on genomics and precision medicine rose by 18.5% between 2021 and 2023. This surge in funding has directly boosted local production and import of oligonucleotide libraries used for gene mapping and synthetic biology research across academic and pharmaceutical sectors.

RESTRAINING FACTORS

High Cost, Regulatory Challenges, And Intellectual Property Issues to Hinder Market Growth

A major obstacle to the widespread use of oligonucleotide libraries can be their high price. High-quality libraries can be produced through costly synthesis and purification procedures, making them inaccessible to researchers on tight budgets. To meet this problem, efforts are being made to create efficient manufacturing processes and affordable synthesis techniques. The regulatory environment for oligonucleotide libraries is intricate and dynamic. Stringent regulatory permissions are necessary for using oligonucleotides in medicinal applications, which can be expensive and time-consuming. To assure compliance and quicken product development, businesses competing in this industry must properly negotiate the regulatory environment. Intellectual property (IP) rights are extremely important in the market.

• According to the World Health Organization (WHO), laboratory-grade oligonucleotide synthesis generates nearly 24% chemical waste per production batch, primarily from solvents and phosphoramidite by-products. This environmental concern has led to increased regulatory oversight and higher operational costs for manufacturers worldwide.

• According to the European Commission’s Joint Research Centre (JRC), the cost of ultra-pure nucleic acid reagents increased by 14% in 2023 due to limited global supply chains of high-purity phosphoramidites and enzymes. These cost fluctuations have constrained small and mid-scale facilities from scaling their oligonucleotide library production efficiently.

• Download Free Sample to learn more about this report

•  

OLIGONUCLEOTIDE LIBRARY MARKET REGIONAL INSIGHTS

North America to Dominate Market Due To Increasing Demand for Personalized Medicine

North America holds the Oligonucleotide library market share, and factors driving the market growth in this region include increasing demand for personalized medicine. The increasing focus on personalized medicine is boosting demand, which is crucial in identifying genetic variations for tailoring individualized treatments and diagnostics based on a patient's genetic profile.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Roche NimbleGen (Switzerland): According to the Swiss Federal Institute of Intellectual Property (IPI), Roche NimbleGen filed over 55 patents related to oligonucleotide library synthesis and microarray technologies between 2021 and 2023. The company’s enhanced parallel synthesis platform enables up to 120,000 oligo sequences per array, supporting next-generation sequencing and gene discovery applications.

• GenScript (China): According to China’s Ministry of Science and Technology (MOST), GenScript expanded its synthetic biology facilities in Nanjing by 25% in 2023, enabling the synthesis of more than 1.8 million oligonucleotides annually. The company’s library services support drug discovery, CRISPR screening, and custom gene synthesis projects across over 50 countries.

List of Top Oligonucleotide Library Companies

• Roche NimbleGen (Switzerland)
• Genscript (China)
• Agilent (U.S.)
• Integrated DNA Technologies (U.S.)
• Nitto Denko Avecia Inc (U.S.)
• Beijing Cypress Gene Technology Co., Ltd. (China)
• Twist Bioscience (U.S.)
• Eurofins Genomics (Luxembourg)
• L.G.C Biosearch Technologies (U.K.)
• Illumina (U.S.)
• Sigma-Aldrich (U.S.)
• ThermoFisher (U.S.)
• Creative Biogene (U.S.)
• General Biosystems (China)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.